ALEXANDER SNYDER. For Profit or For Health? It is Time to Reckon With the Current Pharmaceutical Landscape Through a Systematic Analysis of Monoclonal Anitbodies. Pittsburgh Journal of Technology Law & Policy, v. 21, n. 2, 26 Aug.2021.